Publikationen, an denen er mitarbeitet Miguel Ángel Rodríguez Milla (4)

2021

  1. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses

    Cancer Gene Therapy, Vol. 28, Núm. 1-2, pp. 64-73

2020

  1. Cellular virotherapy increases tumor-infiltrating lymphocytes (Til) and decreases their pd-1+ subsets in mouse immunocompetent models

    Cancers, Vol. 12, Núm. 7, pp. 1-17

2018

  1. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice

    Cancer Immunology, Immunotherapy, Vol. 67, Núm. 10, pp. 1589-1602

  2. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy

    Cancer Research, Vol. 78, Núm. 17, pp. 4891-4901